CD274 and colonic neoplasm: In vitro analysis on various colon cancer cell lines such as HCT116, SW620, and HT-29, indicated that panaxadiol treatment resulted in decreased PD-L1 protein and mRNA levels alongside a reduction in HIF-1α overexpression, as confirmed by Western blotting and immunofluorescence staining [230].